Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma (2017)
- Authors:
- USP affiliated authors: SERAFINI, LUCIANO NEDER - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- DOI: 10.1007/s10637-016-0412-1
- Subjects: EPIGÊNESE GENÉTICA; MEDULOBLASTOMA; ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Investigational New Drugs
- ISSN: 0167-6997
- Volume/Número/Paginação/Ano: v. 35, n. 1, art. 124, 2017
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ANDRADE, Augusto Faria et al. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, v. 35, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10637-016-0412-1. Acesso em: 01 abr. 2026. -
APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Geron, L., Corrêa, C. A. P., Castro-Gamero, A. M., et al. (2017). Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, 35( 1). doi:10.1007/s10637-016-0412-1 -
NLM
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, de Vasconcelos EJR, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1):[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s10637-016-0412-1 -
Vancouver
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, de Vasconcelos EJR, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1):[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s10637-016-0412-1 - H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model
- The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma
- Cytogenetic findings in pediatric radiation-induced atypical meningioma after treatment of medulloblastoma: case report and review of the literature
- Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma
- Differential miRNA expression in medulloblastomas, fetal and non-fetal non neoplastic cerebellum. Identification of potential prognostic markers
- Primary glioblastomas of children and adults and non-neoplastic white matter present differential microRNA expression profile
- Is chromosomal amplification a mechanism of response to chemotherapy in osteossarcoma patient?
- Differential microRNA profiling in pediatric pilocytic astrocytoma and non-neoplastic white matter samples
- Inhibition of carbonic anhydrases (CA) 9 and 12 by indisulam shows significant antiproliferative effects on pediatric and adult glioblastoma cell lines
- Acute lymphoblastic leukemia analyzed by comparative genome hybridization(CGH)
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
